Melanoma and microbiota: Current understanding and future directions.
Cancer Cell
; 42(1): 16-34, 2024 01 08.
Article
en En
| MEDLINE
| ID: mdl-38157864
ABSTRACT
Over the last decade, the composition of the gut microbiota has been found to correlate with the outcomes of cancer patients treated with immunotherapy. Accumulating evidence points to the various mechanisms by which intestinal bacteria act on distal tumors and how to harness this complex ecosystem to circumvent primary resistance to immune checkpoint inhibitors. Here, we review the state of the microbiota field in the context of melanoma, the recent breakthroughs in defining microbial modes of action, and how to modulate the microbiota to enhance response to cancer immunotherapy. The host-microbe interaction may be deciphered by the use of "omics" technologies, and will guide patient stratification and the development of microbiota-centered interventions. Efforts needed to advance the field and current gaps of knowledge are also discussed.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Microbiota
/
Microbioma Gastrointestinal
/
Melanoma
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Cancer Cell
Asunto de la revista:
NEOPLASIAS
Año:
2024
Tipo del documento:
Article
País de afiliación:
Canadá